Insider Trading History of Lfb Biotechnologies S.a.s.u.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Lfb Biotechnologies S.a.s.u. since 2007. The trader's CIK number is 1377942. At the time of the last reporting, Lfb Biotechnologies S.a.s.u. was the Officer of Tg Therapeutics, Inc.. (stock ticker symbol TGTX). Also see all insider trading activities at Tg Therapeutics, Inc..

Note that in the past LFB Biotechnologies S.A.S.U. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Gtc Biotherapeutics Inc (GTCB) by Lfb Biotechnologies S.a.s.u.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 GTCB 3,387,851 $3,625,000 0 $0 0 $0
2008 GTCB 2,018,404 $1,756,011 0 $0 0 $0
2007 GTCB 3,630,000 $4,464,900 0 $0 0 $0

Yearly summary of insider trading at Tg Therapeutics, Inc. (TGTX) by Lfb Biotechnologies S.a.s.u.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 TGTX 114,855 $750,003 0 $0 0 $0


Insider trading activities at 2 companies by Lfb Biotechnologies S.a.s.u.:

1. Gtc Biotherapeutics Inc (GTCB)

2. Tg Therapeutics, Inc. (TGTX)

Table 1. Insider trading of Gtc Biotherapeutics Inc (GTCB) by Lfb Biotechnologies S.a.s.u.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-11-02 GTCB Buy 3,387,851 1.07 3,625,000
2008-02-12 GTCB Buy 2,018,404 .87 1,756,011
2007-01-03 GTCB Buy 3,630,000 1.23 4,464,900

Table 2. Insider trading of Tg Therapeutics, Inc. (TGTX) by Lfb Biotechnologies S.a.s.u.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-02-17 TGTX Buy 114,855 6.53 750,003

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lfb Biotechnologies S.a.s.u. (Officer of Tg Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.